14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
UMAC vs AVEX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Unusual Machines, Inc. (UMAC) is the stronger overall head-to-head candidate over AVEX (AVEX) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). UMAC carries a Unified Composite Score of 44.9/100 (HOLD) at $10.62 (67.6x Forward P/E, -76.1% operating margin), whereas AVEX carries 57.0/100 (HOLD) at $13.10 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While AVEX currently prints a higher short-term Unified Composite Score (57.0/100 HOLD vs. UMAC 44.9/100 HOLD), UMAC captures the overall institutional head-to-head verdict (8–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-76.1% vs. N/A operating margin) and revenue trajectory (+551.3% vs. N/A YoY).
Technical & Structure Timing Caution: UMAC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.6); meanwhile AVEX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UMAC vs AVEX. Trailing 12-month operating profitability (UMAC -76.1% vs AVEX N/A) and valuation multiples (UMAC 67.6x vs AVEX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ UMAC vs AVEX Key Questions & Quantitative Answers
As of Nov 16, 2026, Unusual Machines, Inc. (UMAC) is the stronger overall head-to-head candidate over AVEX (AVEX) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). UMAC carries a Unified Composite Score of 44.9/100 (HOLD) at $10.62 (67.6x Forward P/E, -76.1% operating margin), whereas AVEX carries 57.0/100 (HOLD) at $13.10 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While AVEX currently prints a higher short-term Unified Composite Score (57.0/100 HOLD vs. UMAC 44.9/100 HOLD), UMAC captures the overall institutional head-to-head verdict (8–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-76.1% vs. N/A operating margin) and revenue trajectory (+551.3% vs. N/A YoY). Technical & Structure Timing Caution: UMAC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.6); meanwhile AVEX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
UMAC leads the Growth & Scale pillar: UMAC posts +551.3% YoY revenue growth and +0.0% YoY earnings growth on $44M TTM revenue (34.7% gross margin, -76.1% operating margin), compared with AVEX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, UMAC generates $44M in USD-normalized revenue versus N/A for AVEX. In operating R&D and SG&A reinvestment, UMAC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AVEX.
UMAC screens cheaper on headline valuation multiples. UMAC trades at 67.6x Forward P/E, 67.6x Trailing P/E, N/M PEG, and 10.5x EV/Revenue (unreported FCF margin), whereas AVEX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against UMAC (-14.0% ROE) versus AVEX (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, UMAC carries 186.8% implied volatility (43rd %ile, Balanced (25th–60th %ile)), a 0.69x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (4.19β · 117% Vol realized risk). By comparison, AVEX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.76β · 176% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.